Αποτελέσματα Αναζήτησης
Most patients who are hospitalized with an exacerbation of COPD should be treated with systemic corticosteroids, unless side-effects are limiting [I, A]. A dose of prednisone, 40 mg orally daily, for a 5-day course, is appropriate for most patients, and a dose taper is unnecessary ( Table 3 ) [I, A].
12 Φεβ 2021 · Following up-to-date treatment recommendations such as those provided in the GOLD 2020 strategy report, engaging in chronic disease management, and investing in patient education are important to achieve the greatest benefits of COPD treatment.
2 Οκτ 2018 · Patients with chronic obstructive pulmonary disease (COPD) may experience an acute worsening of respiratory symptoms that results in additional therapy; this event is defined as a COPD exacerbation (AECOPD).
1. Introduction. Chronic obstructive pulmonary disease (COPD) is an important public health issue in both developed and developing countries. It is an important preventable and treatable disease and poses a heavy socioeconomic burden due to its high morbidity and mortality.[] COPD is the third most common cause of death in the world, according to the World Health Organization (WHO).[]
An acute exacerbation of chronic obstructive pulmonary disease (COPD) typically presents with an increased level of dyspnoea, worsening of chronic cough, and/or an increase in the volume and/or purulence of the sputum produced. An exacerbation may represent the first presentation of COPD.
12 Ιουλ 2024 · The Global Initiative for Chronic Obstructive Lung Disease (GOLD), a report produced by the National Heart, Lung, and Blood Institute (NHLBI) and the World Health Organization (WHO), defines an exacerbation of chronic obstructive pulmonary disease (COPD) as "an event characterized by dyspnea and/or cough and sputum that worsens over ≤14 days, wh...
This document provides clinical recommendations for treatment of chronic obstructive pulmonary disease (COPD) exacerbations. Comprehensive evidence syntheses, including meta-analyses, were performed to summarise all available evidence relevant to the Task Force's questions.
